Lipid peroxidation is associated with the inhibitory action of all-trans-retinoic acid on mammary cell transformation

Anticancer Research

Volumn 20, Issue 2 A, 2000, Pages 843-848

  Kubow, S ^a   Woodward, T L ^a   Turner, J D ^b   Nicodemo, A ^a   Long, E ^a   Zhao, X ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Nexia Biotechnologies Ltd   (Canada)

Author keywords

All trans retinoic acid; Inhibition; Lipid peroxidation; Transformed mammary cells

Indexed keywords

INDOMETACIN; LIPID; NORDIHYDROGUAIARETIC ACID; RETINOIC ACID; RETINOL; VIRUS LARGE T ANTIGEN;

ARTICLE; BREAST CELL; CELL TRANSFORMATION; DRUG POTENTIATION; FIBROBLAST; LIPID PEROXIDATION; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; ANTINEOPLASTIC AGENTS; CATTLE; CELL DEATH; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYCLOOXYGENASE INHIBITORS; DRUG SYNERGISM; FEMALE; FIBROBLASTS; INDOMETHACIN; KINETICS; LIPID PEROXIDATION; MAMMARY GLANDS, ANIMAL; NORDIHYDROGUAIARETIC ACID; PREGNANCY; SIMIAN VIRUS 40; TRETINOIN; VITAMIN A;

EID: 0034054740     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Blomhoff R, Green MH, Berg T and Norum KR: Transport and storage of vitamin A. Science 250: 300-403, 1990.
2. Muindi JF, Scher HI, Rigas JR, Warrell Jr, RP and Young CW: Elevated plasma lipid peroxide content correlates with rapid plasma clearance of all-trans-retinoic acid in patients with advanced cancer. Cancer Res 54: 2125-2128, 1994.
3. Kolodziejczyk P and Lown JW: Peroxidase induced metabolism and lipid peroxidase scavenging by antitumor agents. In Therapy. (Emerit, I., ed). New York, Plenum Press. 1990, pp. 323-337.
4. Begin ME: Effect of polyunsaturated fatty acids and of their oxidation products on cell survival. Chem Phys Lipids 45: 269-313, 1987.
5. Cheeseman KH, Burton GW, Ingold KU and Slater TF: Lipid peroxidation and lipid antioxidants in normal and tumor cells. Toxicol Pathol 12: 235-239, 1984.
6. Egan RW, Gale PH, Beveridge GC, Mamett LJ and Kuehl FA, Jr: Direct and indirect involvement of radical scavengers during prostaglandin biosynthesis. Adv Prostaglandin Thromboxane Res 6: 153-155, 1980.
7. Aitokailio-Tailbert A, Karkkainen J, Pantzar P, Wahlstrom T and Yilokarla O: Prostaglandin and thromboxane in breast cancer: Relationship between steroid receptor status and medroxyprogesterone-acetate. Br J Cancer 5: 671-676, 1985.
8. Earashi M, Noguchi M, Kinoshita K and Tanaka M: Effects of eicosanoid synthesis inhibitors on the in vitro growth and prostaglandin E and leukotriene B secretion of a human breast cancer cell line. Oncology 52: 150-155, 1995.
9. Avis IM, Jett M, Boyle T, Vos MD, Moody T, Treston AM, Martinez A and Muishine JL: Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest 97: 806-813, 1996.
10. Samokyszyn VM and Marnett LJ: Hydroperoxide-dependent co-oxidation of 13-cis-retinoic acid by prostaglandin H synthase. J Biol Chem 262: 14119-14133, 1987.
11. Labarca C and Paigen K: A simple, rapid, and sensitive DNA procedure. Anal Biochem 102: 344-352, 1980.
12. Woodward TL, Turner JD and Zhao X: Inhibition of cellular proliferation and modulation of insulin-like growth factor binding proteins by retinoids in a bovine mammary epithelial cell line. J Cell Physiol 167: 488-499, 1996.
13. Folch J, Lees M and Sloanestanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-503, 1957.
14. Kubow S, Goyette N, Kermasha S, Stewart-Phillip J and Koski KG: Vitamin E inhibits fish oil-induced hyperlipidemia and tissue lipid peroxidation in hamsters. Lipids 31: 839-847, 1996.
15. High KA and Kubow S: N-3 fatty acids inhibit defects and fatty acid changes caused by phcnytoin in early gestation in mice. Lipids 29: 771-778, 1994.
16. Zar ZH: Multiple comparisons. In: Biostatistical Analysis. (Zar ZH, ed.), Englewood Cliffs, NJ, Prentice Hall, Inc., 1984, pp. 194-195.
17. Hurnanen D, Cha HC and Kubow S: The protective effect of metallothionein against growth inhibition of human breast cancer cells by retinoic acid. J Pharmacol Exp Therap 283: 1520-1528, 1997.
18. Rice-Evans C and Burdon R: Free radical-lipid interactions and their pathological consequences. Prog. Lipid Res 32: 71-110, 1993.
19. Gonzalez MJ, Schemmel R-A, Dugan Jr. L, Gray JI and Welsch CW: Dietary fish oil inhibits human breast carcinoma: a function of increased lipid peroxidation. Lipids 28: 827-832, 1993.
20. Onodera T and Ashraf M: Detection of hydroxyl radicals in the post-ischemic reperfused heart using salicylate as a trapping agent. J. Mol. Cell Cardiol 23: 365-370, 1991.
21. Lee P-P H and Ip MM: Regulation of proliferation of rat mammary tumor cell by inhibitors of cyclooxygenase and lipoxygenase. Prostaglandins Leukotrienes Essent. Fatty Acids 45: 21-31, 1992.
22. Anderson K, Seed T, Ondery F and Harris J: The selective lipoxygenase inhibitor A631622 reduces PC3 proliferation and initiates morphologic changes consistent with secretion. Anticancer Res 14: 1951-1960, 1994.
23. Toma S, Ismarth L, Raffo P, Dastoli G, De Francisci E, Riccardi L, Palumbo R and Bollag W: Effects of all-trans-retinoic acid and 13-cis-retinoic acid on breast-cancer cell lines: growth inhibition and apoptosis induction. Int J Cancer 70: 619-627, 1997.
24. Kitagawa H and Noguchi M: Comparative effects of piroxicam and esculetin on incidence, proliferation, and cell kinetics of mammary carcinomas induced by 7,12-dimethylbenz(a)anthracene in rats on high and low fat diets. Oncology 51: 407-410, 1994.
25. Vanderhoek JK, Ekborg SL and Bailey JM: Effects of cell growth, differentiation and transformation: clinical involvement of leukotrienes. J. Allergy Clin Immunol 74: 412-417, 1984.
26. Rose DP and Connolly JM: Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res 50: 7139-7144, 1990.